Yiru Wang
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Modeling and Simulation top 5%
- COVID-19 epidemiological studies
Papers in ⓘ
- Nephrology 13
- Acute Kidney Injury Research 5
-
- Anesthesia and Neurotoxicity Research 5
- Co-authors
- Qingquan Liu (12 shared papers)Dawei Ye (4 shared papers)Lisheng Wang (2 shared papers)Xia Shen (5 shared papers)Yongman Lv (12 shared papers)Ranran Xu (4 shared papers)Jie Tang (7 shared papers)Hu Liu (4 shared papers)
- Journals
- Medicine (6 papers)Journal of Ultrasound in Medicine (3 papers)Frontiers in Pharmacology (3 papers)Frontiers in Physiology (3 papers)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Yiru Wang
101 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Infectious Diseases 605
- Modeling and Simulation 98
- Critical Care and Intensive Care Medicine 100
- Developmental Neuroscience 62
- Rehabilitation 96
Countries citing papers authored by Yiru Wang
This map shows the geographic impact of Yiru Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiru Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiru Wang more than expected).
Fields of papers citing papers by Yiru Wang
This network shows the impact of papers produced by Yiru Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiru Wang. The network helps show where Yiru Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yiru Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence Hit paper breakdown → | 2020 | 801 |
| 2 | 2022 | 100 | |
| 3 | 2020 | 97 | |
| 4 | 2018 | 85 | |
| 5 | 2020 | 68 | |
| 6 | 2023 | 58 | |
| 7 | 2018 | 53 | |
| 8 | 2020 | 50 | |
| 9 | 2021 | 50 | |
| 10 | 2014 | 46 | |
| 11 | 2013 | 44 | |
| 12 | Ginsenoside Rb1 inhibit apoptosis in rat model of Alzheimer's disease induced by Aβ1-40. | 2018 | 40 |
| 13 | 2016 | 36 | |
| 14 | 2020 | 32 | |
| 15 | 2018 | 31 | |
| 16 | 2019 | 30 | |
| 17 | 2018 | 29 | |
| 18 | 2020 | 29 | |
| 19 | 2017 | 25 | |
| 20 | 2021 | 24 |
About Yiru Wang
Yiru Wang is a scholar working on Nephrology, Developmental Neuroscience, Critical Care and Intensive Care Medicine, Rehabilitation and Geriatrics and Gerontology, having authored 105 papers that have together received 2.4k indexed citations. Recurring topics across this work include MRI in cancer diagnosis (7 papers), COVID-19 Clinical Research Studies (7 papers), Rheumatoid Arthritis Research and Therapies (6 papers), Long-Term Effects of COVID-19 (5 papers), Anesthesia and Neurotoxicity Research (5 papers), Autophagy in Disease and Therapy (5 papers), Acute Kidney Injury Research (5 papers) and Vasculitis and related conditions (5 papers). The work is most often cited by research in Infectious Diseases (605 citations), Modeling and Simulation (98 citations), Critical Care and Intensive Care Medicine (100 citations), Developmental Neuroscience (62 citations) and Rehabilitation (96 citations). Yiru Wang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Qingquan Liu, Dawei Ye, Lisheng Wang, Xia Shen, Yongman Lv, Ranran Xu, Jie Tang, Hu Liu, Anying Cheng and Fei Huang. Their work appears in journals such as Medicine, Journal of Ultrasound in Medicine, Frontiers in Pharmacology, Frontiers in Physiology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.